These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 32543362

  • 1. Butterfly Structure: A Privileged Scaffold Targeting Tubulin-Colchicine Binding Site.
    Wang Y, Yao Y, Zhu HL, Duan Y.
    Curr Top Med Chem; 2020; 20(17):1505-1508. PubMed ID: 32543362
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
    Li L, Jiang S, Li X, Liu Y, Su J, Chen J.
    Eur J Med Chem; 2018 May 10; 151():482-494. PubMed ID: 29649743
    [Abstract] [Full Text] [Related]

  • 3. Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity.
    Liu X, Pang XJ, Liu Y, Liu WB, Li YR, Yu GX, Zhang YB, Song J, Zhang SY.
    Molecules; 2021 Jul 02; 26(13):. PubMed ID: 34279387
    [Abstract] [Full Text] [Related]

  • 4. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y, Liu W, Tian L, Mao Y, Song C.
    Curr Top Med Chem; 2019 Jul 02; 19(15):1289-1304. PubMed ID: 31210108
    [Abstract] [Full Text] [Related]

  • 5. Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Wu X, Wang Q, Li W.
    Anticancer Agents Med Chem; 2016 Jul 02; 16(10):1325-38. PubMed ID: 26899186
    [Abstract] [Full Text] [Related]

  • 6. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.
    Li W, Sun H, Xu S, Zhu Z, Xu J.
    Future Med Chem; 2017 Oct 02; 9(15):1765-1794. PubMed ID: 28929799
    [Abstract] [Full Text] [Related]

  • 7. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Dong M, Liu F, Zhou H, Zhai S, Yan B.
    Molecules; 2016 Oct 15; 21(10):. PubMed ID: 27754459
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN, Wang JJ, Ji YT, Zhao GD, Tang LQ, Zhang CM, Guo XL, Liu ZP.
    J Med Chem; 2016 Jun 09; 59(11):5341-55. PubMed ID: 27172319
    [Abstract] [Full Text] [Related]

  • 10. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
    Maklad RM, AbdelHafez EMN, Abdelhamid D, Aly OM.
    Bioorg Chem; 2020 Jun 09; 99():103767. PubMed ID: 32325332
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q, Wang Y, Wang R, Lai W, Tang L, Tao Y, Liu Y, Zhang R, Huang L, Xiang H, Zeng S, Gou L, Chen H, Yao Y, Yang J.
    Eur J Med Chem; 2018 Aug 05; 156():162-179. PubMed ID: 30006162
    [Abstract] [Full Text] [Related]

  • 12. Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.
    Wang J, Miller DD, Li W.
    Drug Discov Today; 2022 Mar 05; 27(3):759-776. PubMed ID: 34890803
    [Abstract] [Full Text] [Related]

  • 13. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B, Panda D, Gupta S, Banerjee M.
    Med Res Rev; 2008 Jan 05; 28(1):155-83. PubMed ID: 17464966
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design.
    Cheng J, Wu Y, Wang Y, Wang C, Wang Y, Wu C, Zeng S, Yu Y, Chen Q.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):185-188. PubMed ID: 29102632
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ, Ma CC, Zhang CM, Tang LQ, Liu ZP.
    Eur J Med Chem; 2020 Feb 01; 187():111968. PubMed ID: 31865012
    [Abstract] [Full Text] [Related]

  • 18. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT, Barakat K, Tuszynski JA.
    Electromagn Biol Med; 2009 Feb 01; 28(4):355-64. PubMed ID: 20017626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of pseudolaric acid B with the colchicine site of tubulin.
    Sarkar T, Nguyen TL, Su ZW, Hao J, Bai R, Gussio R, Qiu SX, Hamel E.
    Biochem Pharmacol; 2012 Aug 15; 84(4):444-50. PubMed ID: 22634405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.